For use with nasopharyngeal (NP), nasal, mid-turbinate and oropharyngeal (OP) swab specimens, nasopharyngeal wash/aspirate or nasal wash. A single patient specimen can be tested for SARS-CoV-2 as well as other common respiratory viruses with symptoms that overlap with COVID-19 boosting efficiency and increasing clinical insight.
- Run more efficiently with full automation from sample-to-result.
- Receive easy to interpret results.
- Run multiple assays from a single specimen.
The Aptima® SARS-CoV-2 Assay is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy the Aptima® SARS-CoV-2 Assay for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Aptima® SARS-CoV-2 Assay for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Aptima® SARS-CoV-2 Assay or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.